Xiang Wang

Key Responsibilities • Developed and executed the Medical Excellence strategy, ensuring alignment with organizational goals and strategic initiatives. • Oversaw operational effectiveness of the medical team, managing complexity, performance, budget, and resources. • Led the development and delivery of medical dashboards and performance metrics, collaborating with cross-functional teams to collect, report, and interpret data for informed decision-making and capability building.

Therapeutic Areas: mCRC | GIST | pNET | Prostate Cancer Products: Irinotecan, Sutent, Degarelix Key Responsibilities • Led medical strategy across solid tumor areas, ensuring scientific alignment with clinical evidence and treatment guidelines. • Collaborated with national KOLs to drive academic exchange and support evidence-based clinical practice. • Organized high-quality medical education activities, including advisory boards and scientific training workshops. • Managed key IITs in mCRC, GIST, and prostate cancer to generate clinically relevant evidence. • Developed clear and consistent medical communication for HCPs and provided ongoing scientific training internally.

Responsible for regional medical affairs in the CNS epilepsy therapeutic area, focusing on Depakine. My work includes insight collection and analysis, organizing regional medical education programs, driving small-scale real-world evidence (RWE) generation and publications, and collaborating with national medical teams and cross-functional partners to ensure effective KOL engagement and management.

Attending Neurosurgeon at the Second Affiliated Hospital of Soochow University. Focused on cerebral hemorrhage, traumatic brain injury, and clinical research. Published 20+ papers in SCI and leading Chinese medical journals.